Stocks · Health care · Biological Products, (No Diagnostic Substances)

aTYR PHARMA INC

ATYR Clue Score30
United States Fiscal year ends December CIK 0001339970 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

5 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Paul Schimmel
Director
—
—
—
779,143
$386.69K
—
Sanjay Shukla
President and CEO
—
—
—
153,553
$76.21K
+12.5%
Jill Marie Broadfoot
Chief Financial Officer
—
—
—
37,296
$18.51K
+14.4%
Nancy Denyes
General Counsel
—
—
—
33,124
$16.44K
+11.3%
Jane A Gross
Director
—
—
—
9,750
$4.84K
+62.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.